El Proyecto BIFAP: Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria
The bifap project: database for pharmaco-epidemiological research in primary care
A. Salvador Rosaa,
, J.C. Moreno Pérezb, D. Sonegob, L.A. García Rodríguezc, F.J. de Abajo Iglesiasd, Proyecto Bifap 1
Autor para correspondencia
asalvador@bifap.org
Correspondencia: Proyecto BIFAP. División de Farmacoepidemiología y Farmacovigilancia. Agencia Española del Medicamento. Crta. Majadahonda-Pozuelo, Km 2. 28220 Majadahonda (Madrid). España
Correspondencia: Proyecto BIFAP. División de Farmacoepidemiología y Farmacovigilancia. Agencia Española del Medicamento. Crta. Majadahonda-Pozuelo, Km 2. 28220 Majadahonda (Madrid). España
Leído
3164
Vecesse ha leído el artículo
1611
Total PDF
1553
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 9 | 6 | 15 |
| 2025 11 | 23 | 51 | 74 |
| 2025 10 | 16 | 26 | 42 |
| 2025 9 | 19 | 22 | 41 |
| 2025 8 | 16 | 20 | 36 |
| 2025 7 | 21 | 6 | 27 |
| 2025 6 | 14 | 9 | 23 |
| 2025 5 | 25 | 7 | 32 |
| 2025 4 | 22 | 4 | 26 |
| 2025 3 | 22 | 9 | 31 |
| 2025 2 | 21 | 11 | 32 |
| 2025 1 | 12 | 3 | 15 |
| 2024 12 | 8 | 5 | 13 |
| 2024 11 | 14 | 13 | 27 |
| 2024 10 | 11 | 7 | 18 |
| 2024 9 | 11 | 9 | 20 |
| 2024 8 | 7 | 14 | 21 |
| 2024 7 | 17 | 16 | 33 |
| 2024 6 | 10 | 9 | 19 |
| 2024 5 | 19 | 15 | 34 |
| 2024 4 | 20 | 11 | 31 |
| 2024 3 | 18 | 29 | 47 |
| 2024 2 | 20 | 22 | 42 |
| 2024 1 | 20 | 24 | 44 |
| 2023 12 | 34 | 35 | 69 |
| 2023 11 | 26 | 39 | 65 |
| 2023 10 | 47 | 44 | 91 |
| 2023 9 | 20 | 26 | 46 |
| 2023 8 | 12 | 24 | 36 |
| 2023 7 | 6 | 46 | 52 |
| 2023 6 | 32 | 34 | 66 |
| 2023 5 | 22 | 20 | 42 |
| 2023 4 | 2 | 7 | 9 |
| 2023 3 | 3 | 11 | 14 |
| 2023 2 | 10 | 14 | 24 |
| 2022 1 | 3 | 6 | 9 |
| 2022 12 | 10 | 11 | 21 |
| 2022 11 | 32 | 19 | 51 |
| 2022 10 | 22 | 20 | 42 |
| 2022 9 | 13 | 46 | 59 |
| 2022 8 | 25 | 25 | 50 |
| 2022 7 | 19 | 13 | 32 |
| 2022 6 | 13 | 15 | 28 |
| 2022 5 | 22 | 24 | 46 |
| 2022 4 | 25 | 28 | 53 |
| 2022 3 | 13 | 12 | 25 |
| 2022 2 | 12 | 9 | 21 |
| 2021 1 | 8 | 5 | 13 |
| 2021 12 | 17 | 17 | 34 |
| 2021 11 | 14 | 15 | 29 |
| 2021 10 | 12 | 10 | 22 |
| 2021 9 | 9 | 8 | 17 |
| 2021 8 | 8 | 8 | 16 |
| 2021 7 | 13 | 5 | 18 |
| 2021 6 | 5 | 10 | 15 |
| 2021 5 | 5 | 8 | 13 |
| 2021 4 | 6 | 23 | 29 |
| 2021 3 | 12 | 14 | 26 |
| 2021 2 | 16 | 5 | 21 |
| 2020 1 | 7 | 9 | 16 |
| 2020 12 | 11 | 14 | 25 |
| 2020 11 | 16 | 16 | 32 |
| 2020 10 | 12 | 15 | 27 |
| 2020 9 | 17 | 9 | 26 |
| 2020 8 | 21 | 13 | 34 |
| 2020 7 | 7 | 10 | 17 |
| 2020 6 | 4 | 6 | 10 |
| 2020 5 | 7 | 17 | 24 |
| 2020 4 | 8 | 14 | 22 |
| 2020 3 | 5 | 19 | 24 |
| 2020 2 | 14 | 13 | 27 |
| 2020 1 | 18 | 30 | 48 |
| 2019 12 | 40 | 51 | 91 |
| 2019 11 | 5 | 8 | 13 |
| 2019 10 | 7 | 4 | 11 |
| 2019 9 | 6 | 7 | 13 |
| 2019 8 | 5 | 7 | 12 |
| 2019 7 | 22 | 7 | 29 |
| 2019 6 | 46 | 43 | 89 |
| 2019 5 | 123 | 88 | 211 |
| 2019 4 | 20 | 19 | 39 |
| 2019 3 | 3 | 4 | 7 |
| 2019 2 | 8 | 5 | 13 |
| 2019 1 | 6 | 6 | 12 |
| 2018 12 | 1 | 4 | 5 |
| 2018 11 | 10 | 9 | 19 |
| 2018 10 | 10 | 22 | 32 |
| 2018 9 | 5 | 2 | 7 |
| 2018 8 | 0 | 6 | 6 |
| 2018 7 | 1 | 7 | 8 |
| 2018 5 | 3 | 4 | 7 |
| 2018 4 | 3 | 1 | 4 |
| 2018 3 | 1 | 5 | 6 |
| 2018 2 | 1 | 4 | 5 |
| 2018 1 | 2 | 0 | 2 |
| 2017 12 | 1 | 1 | 2 |
| 2017 11 | 2 | 4 | 6 |
| 2017 10 | 1 | 4 | 5 |
| 2017 9 | 1 | 9 | 10 |
| 2017 8 | 2 | 6 | 8 |
| 2017 7 | 4 | 3 | 7 |
| 2017 6 | 4 | 11 | 15 |
| 2017 5 | 4 | 4 | 8 |
| 2017 4 | 5 | 1 | 6 |
| 2017 3 | 24 | 28 | 52 |
| 2017 2 | 9 | 3 | 12 |
| 2016 1 | 2 | 1 | 3 |
| 2016 12 | 9 | 4 | 13 |
| 2016 11 | 14 | 3 | 17 |
| 2016 10 | 21 | 14 | 35 |
| 2016 9 | 13 | 8 | 21 |
| 2016 8 | 12 | 5 | 17 |
| 2016 7 | 7 | 0 | 7 |
Mostrar todo
